These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 17521775)

  • 1. Tuning immune tolerance with vasoactive intestinal peptide: a new therapeutic approach for immune disorders.
    Pozo D; Gonzalez-Rey E; Chorny A; Anderson P; Varela N; Delgado M
    Peptides; 2007 Sep; 28(9):1833-46. PubMed ID: 17521775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging roles of vasoactive intestinal peptide: a new approach for autoimmune therapy.
    Gonzalez-Rey E; Anderson P; Delgado M
    Ann Rheum Dis; 2007 Nov; 66 Suppl 3(Suppl 3):iii70-6. PubMed ID: 17934101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasoactive intestinal peptide and regulatory T-cell induction: a new mechanism and therapeutic potential for immune homeostasis.
    Gonzalez-Rey E; Delgado M
    Trends Mol Med; 2007 Jun; 13(6):241-51. PubMed ID: 17467339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of cortistatin as a new immunomodulatory factor with therapeutic potential in immune disorders.
    Gonzalez-Rey E; Delgado M
    Mol Cell Endocrinol; 2008 May; 286(1-2):135-40. PubMed ID: 17850953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropeptides as therapeutic approach to autoimmune diseases.
    Gonzalez-Rey E; Delgado-Maroto V; Souza Moreira L; Delgado M
    Curr Pharm Des; 2010; 16(28):3158-72. PubMed ID: 20687881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential applications of vasoactive intestinal Peptide-based therapies on transplantation.
    Souza-Moreira L; Delgado-Maroto V; Delgado M
    Endocr Metab Immune Disord Drug Targets; 2012 Dec; 12(4):333-43. PubMed ID: 23094830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous anti-inflammatory neuropeptides and pro-resolving lipid mediators: a new therapeutic approach for immune disorders.
    Anderson P; Delgado M
    J Cell Mol Med; 2008 Oct; 12(5B):1830-47. PubMed ID: 18554314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Keeping the balance between immune tolerance and pathogen immunity with endogenous neuropeptides.
    Gonzalez-Rey E
    Neuroimmunomodulation; 2010; 17(3):161-4. PubMed ID: 20134192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic treatment of experimental colitis with regulatory dendritic cells generated with vasoactive intestinal peptide.
    Gonzalez-Rey E; Delgado M
    Gastroenterology; 2006 Dec; 131(6):1799-811. PubMed ID: 17087944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disorders.
    Chorny A; Gonzalez-Rey E; Fernandez-Martin A; Pozo D; Ganea D; Delgado M
    Proc Natl Acad Sci U S A; 2005 Sep; 102(38):13562-7. PubMed ID: 16150720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasoactive intestinal peptide-mediated Th17 differentiation: an expanding spectrum of vasoactive intestinal peptide effects in immunity and autoimmunity.
    Yadav M; Goetzl EJ
    Ann N Y Acad Sci; 2008 Nov; 1144():83-9. PubMed ID: 19076367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VIP and tolerance induction in autoimmunity.
    Rosignoli F; Torroba M; Juarranz Y; García-Gómez M; Martinez C; Gomariz RP; Pérez-Leirós C; Leceta J
    Ann N Y Acad Sci; 2006 Jul; 1070():525-30. PubMed ID: 16888219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of vasoactive intestinal peptide in inflammation and autoimmunity.
    Gonzalez-Rey E; Delgado M
    Curr Opin Investig Drugs; 2005 Nov; 6(11):1116-23. PubMed ID: 16312132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of dendritic cell differentiation by vasoactive intestinal peptide: therapeutic applications on autoimmunity and transplantation.
    Chorny A; Gonzalez-Rey E; Delgado M
    Ann N Y Acad Sci; 2006 Nov; 1088():187-94. PubMed ID: 17192565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptides as pleiotropic modulators of the immune response.
    Souza-Moreira L; Campos-Salinas J; Caro M; Gonzalez-Rey E
    Neuroendocrinology; 2011; 94(2):89-100. PubMed ID: 21734355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasoactive intestinal peptide induces CD4+,CD25+ T regulatory cells with therapeutic effect in collagen-induced arthritis.
    Gonzalez-Rey E; Fernandez-Martin A; Chorny A; Delgado M
    Arthritis Rheum; 2006 Mar; 54(3):864-76. PubMed ID: 16508968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasoactive intestinal peptide in the immune system: potential therapeutic role in inflammatory and autoimmune diseases.
    Delgado M; Abad C; Martinez C; Juarranz MG; Arranz A; Gomariz RP; Leceta J
    J Mol Med (Berl); 2002 Jan; 80(1):16-24. PubMed ID: 11862320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo: therapeutic applications in autoimmunity and transplantation.
    Chorny A; Gonzalez-Rey E; Ganea D; Delgado M
    Ann N Y Acad Sci; 2006 Jul; 1070():190-5. PubMed ID: 16888164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasoactive intestinal peptide regulates Th17 function in autoimmune inflammation.
    Leceta J; Gomariz RP; Martinez C; Carrión M; Arranz A; Juarranz Y
    Neuroimmunomodulation; 2007; 14(3-4):134-8. PubMed ID: 18073504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasoactive intestinal peptide induces cell cycle arrest and regulatory functions in human T cells at multiple levels.
    Anderson P; Gonzalez-Rey E
    Mol Cell Biol; 2010 May; 30(10):2537-51. PubMed ID: 20231362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.